Biotech

All Articles

Roivant unveils brand new 'vant' to advance Bayer hypertension med

.Matt Gline is back along with a brand-new 'vant' company, after the Roivant Sciences chief executiv...

Viridian eye disease period 3 smash hits, evolving press to competing Amgen

.Viridian Therapeutics' stage 3 thyroid eye illness (TED) clinical trial has attacked its key as wel...

Bain introduces $3B fund for life science business

.Along with a sturdy performance history for pinpointing diamonds in the rough, Bain Capital Lifespa...

Genentech's cancer restructure brought in 'for scientific causes'

.The latest selection to combine Genentech's two cancer divisions was actually made for "clinical re...

Tern oral GLP-1 reveals 5% weight-loss at 1 month at greatest dose

.Terns Pharmaceuticals' selection to lose its own liver disease aspirations might yet pay off, after...

Merck, Daiichi regular early results in little cell bronchi cancer with upgraded ADC information

.Merck &amp Co.'s long-running initiative to land a hit on small tissue lung cancer cells (SCLC) has...

Boehringer, Bayer advancement lung cancer drugs toward Astra battle

.Some patients along with non-small cell bronchi cancer cells (NSCLC) possess mutations in a gene na...

MBX aims for $136M IPO to take rival to Ascendis in to stage 3

.MBX has actually expanded programs to take in over $136 thousand from its own IPO as the biotech lo...

Relay bust cancer records tee up clash with AstraZeneca's Truqap

.Relay Therapeutics has beaten its survival goal in a first-in-human boob cancer cells study, settin...

AZ details AI-enabled TROP2 biomarker method for Daiichi ADC

.AstraZeneca has used expert system to develop a special biomarker for its own Daiichi Sankyo-partne...